Dr. Ana C. Krieger, MD

Dr. Krieger practices at Columbia University Irving Medical Center in New York, New York.

Dr. Krieger's NPI, 1922092899, was assigned on September 7, 2005. Dr. Krieger graduated from Federal University of Rio Grande do Sul School of Medicine in 1992. Dr. Krieger holds New York license 230104.

Dr. Krieger's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Krieger's primary practice is Columbia University Irving Medical Center in New York, New York. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Krieger to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krieger practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Krieger's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Krieger is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Krieger's licenses on file in 5 states: New York, Florida, Connecticut, New Jersey and Illinois.

Dmand AI lists sleep apnea among the conditions Dr. Krieger treats.

CMS data shows 668 Medicare services from Dr. Krieger across 10 procedure codes in 2024, for 461 Medicare patients. Medicare paid $171,042 for them. Every service was in an office.

CMS counts 461 Medicare patients who saw Dr. Krieger in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Krieger's median patient age at 57, with 41% women.

In 2024, Dr. Krieger wrote 366 Medicare Part D claims for 82 patients. 91% of them were for generic drugs. CMS names the drug for 253 of them, across 9 drugs with 11 or more claims each, at $127,260 in total drug cost. In 2023, CMS named 375 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Krieger for performance year 2024, reported through an alternative payment model (APM). Dr. Krieger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krieger as offering telehealth.

Dmand AI links 64 papers to Dr. Krieger, published from 2009 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Sleep Apnea, Obstructive, Polysomnography and Sleep Wake Disorders. Dr. Krieger has published most often in J Clin Sleep Med. Dr. Krieger's most frequent co-authors are Daniel A. Barone, MD, Daniel B. Green, MD and Gloria Chia-Yi Chiang, MD.

Dmand AI links Dr. Krieger to 7 clinical trials. 2 are still active or recruiting. Conditions studied include Sleep Apnea, Obstructive, Sleep Apnea Syndromes and Apnea. Weill Medical College of Cornell University sponsors the most, 5.

CMS Open Payments shows 5 general payments to Dr. Krieger from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 100% of the total. Philips Electronics North America Corporation paid the most, $6,085.

Dmand AI lists 6 awards for Dr. Krieger, most recently America's Most Honored Professionals - Top 1% in 2023.

Dr. Krieger graduated from Federal University of Rio Grande do Sul School of Medicine in 1992.

Dr. Krieger is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.